1. Home
  2. KIRK vs BTAI Comparison

KIRK vs BTAI Comparison

Compare KIRK & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KIRK
  • BTAI
  • Stock Information
  • Founded
  • KIRK 1966
  • BTAI 2017
  • Country
  • KIRK United States
  • BTAI United States
  • Employees
  • KIRK N/A
  • BTAI N/A
  • Industry
  • KIRK Diversified Commercial Services
  • BTAI Biotechnology: Pharmaceutical Preparations
  • Sector
  • KIRK Miscellaneous
  • BTAI Health Care
  • Exchange
  • KIRK Nasdaq
  • BTAI Nasdaq
  • Market Cap
  • KIRK 25.9M
  • BTAI 28.7M
  • IPO Year
  • KIRK 2002
  • BTAI 2018
  • Fundamental
  • Price
  • KIRK $1.70
  • BTAI $0.36
  • Analyst Decision
  • KIRK Buy
  • BTAI Strong Buy
  • Analyst Count
  • KIRK 2
  • BTAI 4
  • Target Price
  • KIRK $4.50
  • BTAI $5.00
  • AVG Volume (30 Days)
  • KIRK 209.8K
  • BTAI 949.6K
  • Earning Date
  • KIRK 12-06-2024
  • BTAI 11-14-2024
  • Dividend Yield
  • KIRK N/A
  • BTAI N/A
  • EPS Growth
  • KIRK N/A
  • BTAI N/A
  • EPS
  • KIRK N/A
  • BTAI N/A
  • Revenue
  • KIRK $458,411,000.00
  • BTAI $2,276,000.00
  • Revenue This Year
  • KIRK N/A
  • BTAI $164.86
  • Revenue Next Year
  • KIRK $0.72
  • BTAI $69.74
  • P/E Ratio
  • KIRK N/A
  • BTAI N/A
  • Revenue Growth
  • KIRK N/A
  • BTAI 83.25
  • 52 Week Low
  • KIRK $1.39
  • BTAI $0.35
  • 52 Week High
  • KIRK $3.50
  • BTAI $4.17
  • Technical
  • Relative Strength Index (RSI)
  • KIRK 44.43
  • BTAI 32.49
  • Support Level
  • KIRK $1.70
  • BTAI $0.35
  • Resistance Level
  • KIRK $1.85
  • BTAI $0.52
  • Average True Range (ATR)
  • KIRK 0.13
  • BTAI 0.06
  • MACD
  • KIRK -0.01
  • BTAI -0.00
  • Stochastic Oscillator
  • KIRK 2.42
  • BTAI 2.92

About KIRK Kirkland's Inc. COMMONSTOCK

Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: